OncoSec Medical Incorporated (ONCS) Stock Income Statement
NASDAQ:ONCS - Nasdaq - US68234L4059 - Common Stock - Currency: USD
| TTM (2023-1-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | 2019 (2019-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 32.65M | 37.01M | 48.38M | 43.41M | 30.42M | |||
| Research and Development | 21.77M | 25.82M | 34.10M | 25.10M | 18.45M | |||
| Selling, General, and Administrative Expenses | 10.88M | 11.19M | 14.28M | 18.31M | 11.97M | |||
| Operating Income | -32.65M | -37.01M | -48.38M | -43.41M | -30.42M | |||
| Interest Income/Expense | -126.42K | -530.58K | -159.95K | 100.00K | -300.00K | |||
| Other Income/Expense | 56.91K | 28.86K | -700.00 | 190.00K | 440.00K | |||
| Non Recurring Items | N/A | 0.00 | 960.79K | N/A | 0.00 | |||
| Income Before Taxes | -32.72M | -37.51M | -47.58M | -43.13M | -30.27M | |||
| Income Tax | -3.33M | -3.33M | -2.41M | -870.00K | 0.00 | |||
| Net Income | -29.39M | -34.18M | -45.17M | -42.25M | -30.28M | |||
| EBITDA | -32.40M | -36.75M | -48.14M | -43.19M | -30.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -15.24 | -19.13 | -30.20 | -2.56 | -4.29 | |||
| Non GAAP EPS | N/A | -19.14 | -31.46 | -63.58 | -94.82 | |||
| Statistics | ||||||||
All data in USD